<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39555242</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2590-1362</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Vaccine: X</Title><ISOAbbreviation>Vaccine X</ISOAbbreviation></Journal><ArticleTitle>Trust in the science behind COVID-19 vaccines as a driver of vaccine acceptance in the United States, 2021-2023.</ArticleTitle><Pagination><StartPage>100576</StartPage><MedlinePgn>100576</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100576</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvacx.2024.100576</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To evaluate changes in public trust in the science behind COVID-19 vaccines in the United States (US) from 2021 to 2023, and to assess how loss of a family member or close friend to COVID-19, influences this trust and vaccine acceptance.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Using stratified random sampling for key demographic variables, including age, gender, race/ethnicity, region, and education level, the study analyzes data from a series of cross-sectional surveys conducted in 2021, 2022 and 2023. Descriptive statistics were employed to summarize the socio-demographic characteristics of the respondents and their levels of trust in science and vaccine acceptance. Weighted logistic regression models were applied to assess the relationships between trust in science, vaccine acceptance, and socio-demographic factors. These models controlled for potential confounding variables and allowed for the estimation of adjusted odds ratios (aOR) and 95% confidence intervals (CI), highlighting the key predictors of vaccine acceptance and willingness to receive future recommended boosters.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The results indicate that trust in science remained relatively stable over the study period and continued to be a strong predictor of vaccine acceptance, which was higher among male respondents, those with university degrees, and those with higher than median income. Notably, the experience of personal loss was significantly related to an individual's trust in science and vaccine acceptance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Trust in the science behind COVID-19 vaccines appears to have been a crucial factor in US vaccine acceptance, with respondents who expressed higher trust being significantly more likely to accept the vaccine and express willingness to take future boosters. To maintain and enhance public trust in vaccination programs, trust in health communication from public sources, particularly the CDC, must be strengthened, as trust in the CDC was also found to be significantly correlated with both vaccine acceptance and future booster uptake. Personal experiences of loss due to COVID-19 were important predictors of trust in science and vaccine acceptance, highlighting the need for public health communications to be sensitive to the emotional impact of loss and grief along with the diverse socio-economic and educational backgrounds of the US population.</AbstractText><CopyrightInformation>© 2024 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>White</LastName><ForeName>Trenton M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Graduate School of Public Health &amp; Health Policy, City University of New York (CUNY), New York City, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyka</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Graduate School of Public Health &amp; Health Policy, City University of New York (CUNY), New York City, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabin</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Graduate School of Public Health &amp; Health Policy, City University of New York (CUNY), New York City, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Mohandes</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Public Health &amp; Health Policy, City University of New York (CUNY), New York City, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vaccine X</MedlineTA><NlmUniqueID>101748769</NlmUniqueID><ISSNLinking>2590-1362</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">Survey</Keyword><Keyword MajorTopicYN="N">Trust in science</Keyword><Keyword MajorTopicYN="N">Vaccine acceptance</Keyword></KeywordList><CoiStatement>The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Study funding was provided by Moderna, Inc., to the City University of New York (CUNY) Research Foundation. Authors retained full autonomy in the design of the study; the development of the survey instrument; the collection, analysis, and interpretation of data; the presentation of results; and the decision to submit the article for publication. All authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39555242</ArticleId><ArticleId IdType="pmc">PMC11566880</ArticleId><ArticleId IdType="doi">10.1016/j.jvacx.2024.100576</ArticleId><ArticleId IdType="pii">S2590-1362(24)00149-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>U.S. Department of Health and Human Services. Fact Sheet: COVID-19 Public Health Emergency Transition Roadmap. https://www.hhs.gov/about/news/2023/02/09/fact-sheet-covid-19-public-health-emergency-transition-roadmap.html.</Citation></Reference><Reference><Citation>AlShurman B.A., Khan A.F., Mac C., Majeed M., Butt Z.A. What demographic, social, and contextual factors influence the intention to use COVID-19 vaccines: a scoping review. Int J Environ Res Public Health. 2021;18:9342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8431323</ArticleId><ArticleId IdType="pubmed">34501932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S., et al. Association of death or illness from COVID-19 among family and friends on vaccine uptake within four months of the Emergency Use authorization. findings from a national survey in the United States. Vaccine. 2023;41:1911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9837229</ArticleId><ArticleId IdType="pubmed">36682984</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmoneim S.A., et al. COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2022;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9611447</ArticleId><ArticleId IdType="pubmed">36288039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C. Largest post-pandemic survey finds trust in scientists is high. Nature. 2024 doi: 10.1038/D41586-024-00420-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/D41586-024-00420-1</ArticleId><ArticleId IdType="pubmed">38356001</ArticleId></ArticleIdList></Reference><Reference><Citation>Peña J.M., Schwartz M.R., Hernandez-Vallant A., Sanchez G.R. Social and structural determinants of COVID-19 vaccine uptake among racial and ethnic groups. J Behav Med. 2023;46:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9846662</ArticleId><ArticleId IdType="pubmed">36652085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus J.V., et al. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun. 2022;13:1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9247969</ArticleId><ArticleId IdType="pubmed">35778396</ArticleId></ArticleIdList></Reference><Reference><Citation>Calnan M., Zinn J.O., Douglass T.E. The Sociology of Vaccines. F1000Res. 2022;11:891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353197</ArticleId><ArticleId IdType="pubmed">35967974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus J.V., et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;2023:1–10. doi: 10.1038/s41591-022-02185-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02185-4</ArticleId><ArticleId IdType="pubmed">36624316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus J.V., et al. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023. Nat Med. 2024;2024:1–5. doi: 10.1038/s41591-024-02939-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02939-2</ArticleId><ArticleId IdType="pmc">PMC11186753</ArticleId><ArticleId IdType="pubmed">38684861</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Census Bureau. American Community Survey Data Releases 2018-2022. https://www.census.gov/programs-surveys/acs/news/data-releases.html (2022).</Citation></Reference><Reference><Citation>Lazarus J.V., et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020;27:225–228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573523</ArticleId><ArticleId IdType="pubmed">33082575</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagan, N. et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. https://doi.org/10.1056/NEJMoa2101765384, 1412–1423 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7944975</ArticleId><ArticleId IdType="pubmed">33626250</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof S.Y., et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021;398:1407–1416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8489881</ArticleId><ArticleId IdType="pubmed">34619098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan Raza S., et al. Unlocking infodemics and mysteries in COVID-19 vaccine hesitancy: Nexus of conspiracy beliefs, digital informational support, psychological Well-being, and religious fatalism. Vaccine. 2023;41:1703–1715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894779</ArticleId><ArticleId IdType="pubmed">36754765</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Mohandes A., et al. COVID-19 vaccine acceptance among adults in four major US metropolitan areas and nationwide. Sci Rep. 2021;11:1–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8569192</ArticleId><ArticleId IdType="pubmed">34737319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndugga, N., Hill, L., Artiga, S. &amp; Haldar, S. Latest Data on COVID-19 Vaccinations by Race/Ethnicity | KFF. Kaiser Family Foundation https://www.kff.org/coronavirus-covid-19/issue-brief/latest-data-on-covid-19-vaccinations-by-race-ethnicity/ (2022).</Citation></Reference><Reference><Citation>Kerr J., Panagopoulos C., van der Linden S. Political polarization on COVID-19 pandemic response in the United States. Pers Individ Dif. 2021;179</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8631569</ArticleId><ArticleId IdType="pubmed">34866723</ArticleId></ArticleIdList></Reference><Reference><Citation>Latkin C., et al. A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US. Hum Vaccin Immunother. 2022;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9196649</ArticleId><ArticleId IdType="pubmed">35417302</ArticleId></ArticleIdList></Reference><Reference><Citation>Latkin C.A., et al. Behavioral and attitudinal correlates of trusted sources of COVID-19 vaccine information in the US. Behavioral Sci. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8074305</ArticleId><ArticleId IdType="pubmed">33924118</ArticleId></ArticleIdList></Reference><Reference><Citation>Neely S.R., Eldredge C., Ersing R., Remington C. Vaccine hesitancy and exposure to misinformation: a survey analysis. J Gen Intern Med. 2022;37:179–187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528483</ArticleId><ArticleId IdType="pubmed">34671900</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz, P. J. &amp; Nakamoto, K. The perils of misinformation: when health literacy goes awry. Nature Reviews Nephrology 2022 18:318, 135–136 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8739684</ArticleId><ArticleId IdType="pubmed">34997231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T., et al. Revealing public opinion towards covid-19 vaccines with twitter data in the united states: spatiotemporal perspective. J Med Internet Res. 2021;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437406</ArticleId><ArticleId IdType="pubmed">34346888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., et al. Message Fatigue and COVID-19 Vaccine Booster Uptake in the United States. J Health Commun. 2024 doi: 10.1080/10810730.2023.2282036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10810730.2023.2282036</ArticleId><ArticleId IdType="pubmed">37962284</ArticleId></ArticleIdList></Reference><Reference><Citation>Khubchandani J., Sharma S., Price J.H., Wiblishauser M.J., Webb F.J. COVID-19 Morbidity and Mortality in Social Networks: Does It Influence Vaccine Hesitancy? Int J Environ Res Public Health. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470484</ArticleId><ArticleId IdType="pubmed">34574373</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Wood C.E., Kostkova P. Vaccine hesitancy and behavior change theory-based social media interventions: a systematic review. Transl Behav Med. 2022;12:243–272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8848992</ArticleId><ArticleId IdType="pubmed">34850217</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Lazić, &amp; I. Žeželj. A systematic review of narrative interventions: Lessons for countering anti-vaccination conspiracy theories and misinformation. https://doi.org/10.1177/0963662521101188130, 644–670 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34006153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuru O., et al. The effects of scientific messages and narratives about vaccination. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7990169</ArticleId><ArticleId IdType="pubmed">33760856</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>